GreenLight Biosciences, Inc. has developed a unique Cell-Free bioprocessing platform capable of producing RNA sequences of exceptional fidelity in a fully-scalable fashion at a fraction of the costs of other technologies. The company is focused on development of dsRNA-based products for crop agriculture, and is developing further RNA offerings in the areas of public health, vaccine development and human therapeutics. GreenLight has established partnerships with some of the world's leading chemical and agricultural companies to develop and commercialize its products.
GreenLight is committed to helping reduce the harmful effects of chemical emissions into our environment and to doing its part in fighting global climate change. GreenLight is an equal-opportunity employer and believes in diversity and gender-equality in the work place.